《纽约时报》中国报道引爆美国舆论：中美已走上不同的AI道路

Core Viewpoint - The New York Times published a report on January 2, 2026, highlighting the success of Alibaba's AI model in early detection of pancreatic cancer, which has shocked American readers [1]. Group 1: AI Model and Its Impact - The AI model, named DAMO PANDA, developed by Alibaba's DAMO Academy, is designed to identify early-stage pancreatic cancer using non-enhanced CT scans [8]. - The model has analyzed over 180,000 CT images since November 2014, helping to detect 24 cases of pancreatic cancer, with 14 being early-stage [8]. - The AI has demonstrated a 93% accuracy rate in identifying pancreatic cancer patients from over 20,000 non-enhanced CT tests [9]. Group 2: Clinical Application and Recognition - The AI model has been recognized as a "breakthrough medical device" by the FDA, which accelerates the review process for advanced diagnostic tools [9]. - The deployment of the PANDA model has been credited with saving lives, as it identified cancer in patients who did not exhibit any symptoms [8]. Group 3: Public Reaction and Discussion - The report has sparked significant discussion among American readers, with many praising the practical application of AI in solving real-world health issues [10]. - Comments on the article reflect a sense of admiration for China's approach to AI, contrasting it with the focus of American tech giants on replacing jobs rather than addressing health challenges [10][14]. - Prominent figures, including Eric Topol, have endorsed the research, noting its thorough validation prior to implementation [16].